Synergistic anti-proliferative and pro-apoptotic activities of 5F and cisplatin in human non-small cell lung cancer NCI-H23 cells

Two-drug combination chemotherapy, often including cisplatin and one other drug, remains the standard of care for patients with advanced non-small cell lung cancer (NSCLC). To improve the treatment of late-stage NSCLC and decrease the toxicity of combination chemotherapy, the search for novel drugs...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Yuchan, Li, Wende, Deng, Wusheng, Gan, Yuhong, Wu, Kefeng, Sun, Jie
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2017
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652240/
https://www.ncbi.nlm.nih.gov/pubmed/29098029
http://dx.doi.org/10.3892/ol.2017.6848

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5652240/
https://www.ncbi.nlm.nih.gov/pubmed/29098029
http://dx.doi.org/10.3892/ol.2017.6848

Ejemplares similares